Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days £260.00 £353.00 Friday, 10th May 2024 HCM.L stock ended at £352.00. This is 13.55% more than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 3.22% from a day low at £342.00 to a day high of £353.00.
90 days £202.50 £353.00
52 weeks £173.60 £353.00

Historical Hutchison China Meditech Ltd ADR (Sponsored) prices

Date Open High Low Close Volume
Apr 04, 2024 £266.00 £270.60 £266.00 £267.00 17 761
Apr 03, 2024 £275.00 £275.00 £269.00 £270.00 75 012
Apr 02, 2024 £267.50 £267.50 £267.50 £267.50 0
Mar 28, 2024 £266.50 £273.00 £261.51 £267.50 18 840
Mar 27, 2024 £271.50 £272.50 £261.91 £264.50 60 931
Mar 26, 2024 £260.26 £269.50 £256.50 £264.00 36 165
Mar 25, 2024 £271.50 £271.50 £264.50 £267.00 54 909
Mar 22, 2024 £255.50 £266.04 £254.45 £262.00 73 487
Mar 21, 2024 £272.50 £277.00 £265.00 £275.50 59 696
Mar 20, 2024 £274.00 £275.50 £263.50 £271.00 27 076
Mar 19, 2024 £269.30 £273.00 £265.00 £271.00 130 132
Mar 18, 2024 £270.10 £279.50 £267.52 £275.00 73 804
Mar 15, 2024 £274.50 £283.50 £274.50 £283.00 130 514
Mar 14, 2024 £276.50 £277.00 £254.00 £261.50 282 677
Mar 13, 2024 £272.00 £303.00 £272.00 £289.50 232 764
Mar 12, 2024 £248.50 £261.50 £248.50 £261.00 86 885
Mar 11, 2024 £240.00 £240.00 £231.57 £235.50 12 222
Mar 08, 2024 £231.50 £239.50 £231.50 £235.00 31 086
Mar 07, 2024 £237.00 £237.00 £237.00 £237.00 0
Mar 06, 2024 £229.00 £241.00 £229.00 £237.00 69 416
Mar 05, 2024 £219.50 £228.85 £216.50 £219.00 23 000
Mar 04, 2024 £238.00 £243.50 £232.00 £237.00 29 373
Mar 01, 2024 £249.50 £253.50 £238.06 £241.00 14 240
Feb 29, 2024 £244.00 £263.48 £238.50 £238.50 27 162
Feb 28, 2024 £234.22 £277.39 £232.50 £244.00 55 216
Click to get the best stock tips daily for free!

About Hutchison China Meditech Ltd ADR (Sponsored)

Hutchison China Meditech Ltd ADR (Sponsored) HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and renal cell carcinoma, colorectal cancer (CRC), and gastric cancer (GC); and Fruquintinib, an inhibitor for ... HCM.L Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT